Company Filing History:
Years Active: 2001-2002
Title: Wade S. Blair: Innovator in Antiviral Research
Introduction
Wade S. Blair is a notable inventor based in Clinton, CT (US). He has made significant contributions to the field of antiviral research, holding 2 patents that focus on innovative compounds and assay methods. His work has implications for the treatment of serious health conditions, including HIV and AIDS.
Latest Patents
One of Wade S. Blair's latest patents is for antiviral indoleoxoacetyl piperazine derivatives. This invention provides compounds that possess drug and bio-affecting properties, along with their pharmaceutical compositions and methods of use. The compounds exhibit unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators, or HIV entry inhibitors. More specifically, this invention is aimed at the treatment of HIV and AIDS. Another significant patent is related to a method of assaying for RNA: protein interactions. This invention pertains to an in vivo method of assaying the interaction of RNA with proteins and includes a kit suitable for use in connection with such a method.
Career Highlights
Wade S. Blair has worked with prominent organizations, including Bristol-Myers Squibb Company and Duke University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of antiviral research.
Collaborations
Some of his notable coworkers include Milind Deshpande and Haiquan Fang. Their collaborative efforts have contributed to the advancement of research in their respective fields.
Conclusion
Wade S. Blair's contributions to antiviral research through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical field, particularly in the treatment of HIV and AIDS.